This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore various ways to lower utility bills and manage your household expenses more efficiently. Take action and save money now!
16,314 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Tesla’s push expand self-driving faces a new setback in the Netherlands, extending the timeline for European rollout ...
SpaceX is one of the most anticipated names in tech and aerospace. This guide shows everyday investors how to beat wa...
The artificial intelligence (ai) trade is splitting into two distinct lanes: training and inference. This guide expla...
A high-profile White House move puts Silicon Valley on center stage. As trump appoints mark zuckerberg to a new scien...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
As the 2026 earnings season unfolds, investors want real, actionable insights on fidus (FDUS) 2026 earnings. This ana...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
A security firm reports that researchers used Claude Mythos AI to help build a macOS kernel exploit. The incident spo...
Retirement is a chance to design a life with purpose. Explore how varying activities nurture meaning and mental healt...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
A seasoned fund trimmed a big winner after a meteoric run. This article breaks down the why behind the move, the numb...